Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Hungary Italy The Netherlands Poland +2
  • Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Germany Greece Hungary Italy The Netherlands +2
  • Study of roginolisib, dostarlimab and docetaxel combination for patients with advanced non-small cell lung cancer who did not respond to previous immunotherapy and chemotherapy

    Not recruiting

    1 1 1 1
    Belgium Italy Spain
  • Study Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    France Greece Ireland Spain
  • Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    1 1 1 1
    Belgium France Germany Italy Spain